-
The need for more data and research is just one of the barriers to larger-scale use of positron emission tomography/CT (PET/CT). Another issue is availability of resources.
-
Secondary cancers occur in 5-10% of patients with head and neck cancer, but there has been no industry standard for identifying such cancers. Consequently, many centers use numerous tests including ultrasound, X-rays, CT, and blood work to uncover secondary disease.
-
Preliminary findings suggest that positron emission tomography/CT (PET/CT), using the radiotracer fluoro-L-thymidine (FLT), might be able to quickly show whether chemotherapy is working in patients with acute myelogenous leukemia (AML).
-
While there is some improvement in colorectal cancer screening rates since 2000, still only about half of men and women over age 50 received the recommended screening tests in 2005, according to a report in the July 2008 issue of Cancer Epidemiology, Biomarkers, and Prevention.
-
A new multicenter study suggests that a simple ultrasound exam of the heel might be able to indicate whether a woman is at risk for an osteoporotic-related fracture.
-
It can be frustrating, and even heart-breaking, to find out that a lengthy course of treatment was not effective. This statement is particularly relevant for fast-growing diseases such as cervical cancer.
-
Adherence to therapy is critical to preventing recurrence in breast cancer patients, but new findings suggest that as many as 13% of women fail to complete the recommended course of radiation following breast cancer surgery.
-
Researchers at Durham, NC-based Duke University Medical Center have developed a hybrid imager that could improve detection of breast cancer while also relieving the discomfort associated with traditional breast screening exams such as mammography.
-
-
Medical ethics is at the center of a case in the state of North Carolina, whereby the state Department of Corrections is at odds with the North Carolina Medical Board (NCMB) over physician participation in executions.
